I agree that this site is using cookies. You can find further informations here.
X
Gatzemeier, U.
103  results:
Search for persons X
?
1

Prognostic factors in patients with advanced non-small cell..:

Pirker, R. ; Pereira, J.R. ; Szczesna, A....
Lung Cancer.  77 (2012)  2 - p. 376-382 , 2012
Link: https://doi.org/10.1016/..
 
?
2

Sepsis und Aspergillose bei einer Patientin mit nicht-klein..:

Hermes, A ; Gatzemeier, U ; Schultz, H.
DMW - Deutsche Medizinische Wochenschrift.  136 (2011)  12 - p. 582-585 , 2011
Link: https://doi.org/10.1055/..
 
?
3

9161 FLEX study: Prognostic factors in NSCLC:

Pirker, R. ; Pereira, J. Rodrigues ; Szczesna, A....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 554 , 2009
Link: https://doi.org/10.1016/..
 
?
4

9160 Molecular and clinical biomarkers of outcome with cetu..:

O'Byrne, K. ; Pereira, J. Rodrigues ; vonPawel, J....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 553 , 2009
Link: https://doi.org/10.1016/..
 
?
5

CN5 EXPLORATORY ECONOMIC EVALUATION OF ADJUVANT TREATMENT O..:

Gyldmark, M ; Gatzemeier, U ; Nicolson, M..
Value in Health.  11 (2008)  6 - p. A357 , 2008
Link: https://doi.org/10.1016/..
 
?
6

Advanced non-small cell lung cancer therapy: historical and..:

Reck, M. ; Gatzemeier, U.
Targeted Oncology.  3 (2008)  3 - p. 135-147 , 2008
Link: https://doi.org/10.1007/..
 
?
7

6521 POSTER Is pemetrexed more effective in patients with n..:

Peterson, P. ; Park, K. ; Fossella, F....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 363-364 , 2007
Link: https://doi.org/10.1016/..
 
?
8

6568 POSTER Phase II trial of the novel epothilone ZK-EPO a..:

Gatzemeier, U. ; vonPawel, J. ; Eschbach, C....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 378 , 2007
Link: https://doi.org/10.1016/..
 
?
9

1BA Phase III study of pemetrexed plus cisplatin versus gem..:

Manegold, C. ; Digumarti, R. ; Zukin, M....
European Journal of Cancer Supplements.  5 (2007)  6 - p. 9 , 2007
Link: https://doi.org/10.1016/..
 
?
10

6607 POSTER Preliminary findings of a phase I dose-escalati..:

Reck, M. ; Frickhofen, N. ; Gatzemeier, U....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 390 , 2007
Link: https://doi.org/10.1016/..
 
?
11

Nichtkleinzelliges Lungenkarzinom: Palliative Chemotherapie..:

Reck, M. ; Deppermann, K.M. ; Gatzemeier, U..
Der Onkologe.  12 (2006)  8 - p. 761-768 , 2006
Link: https://doi.org/10.1007/..
 
?
12

O-099 XYOTAX™ vs. docetaxel for the second-line treatment o..:

Bonomi, P. ; Paz-Ares, L. ; Langer, C....
Lung Cancer.  49 (2005)  - p. S35 , 2005
Link: https://doi.org/10.1016/..
 
?
13

Erstlinientherapie des kleinzelligen Lungenkarzinoms (SCLC):

Reck, M. ; Niederle, N. ; Thomas, M..
Der Onkologe.  11 (2005)  7 - p. 722-729 , 2005
Link: https://doi.org/10.1007/..
 
?
14

O-163 Prevention of thromboembolic complications with the l..:

Gatzemeier, U. ; Freund, M. ; Haas, S....
Lung Cancer.  49 (2005)  - p. S56 , 2005
Link: https://doi.org/10.1016/..
 
?
15

P-495 Indisulam (E7070) in combination with carboplatin in ..:

Hermes, A. ; Reck, M. ; Dittrich, C....
Lung Cancer.  49 (2005)  - p. S247 , 2005
Link: https://doi.org/10.1016/..
 
1-15